Discover five myopia companies racing to go beyond glasses, as myopia is set to affect half the world by 2050.

Delve into Labiotech's October oncology roundup and find out about the news that caught our attention this last month.

Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer, as Hansoh Pharma and Medilink bring momentum with ...

Discover Novo's pipeline in 2026, as it recently set out a new plan to reach $23 billion in risk-adjusted pipeline sales by ...

Targeting sleep architecture – the structural organization of distinct sleep stages (REM and non-REM) – has begun to emerge as an interesting therapeutic approach to slow down neurodegeneration and ...

Metabolic diseases affect around 1.54 billion people worldwide and have more than doubled in prevalence from 11.9% in 2000 to 28.4% in 2023. The past few years, however, have seen much attention go to ...

Artificial intelligence (AI) has taken the biotech industry by storm, leading to numerous AI drug discovery companies operating in the field, as the technology enables them to speed up the drug ...

Keep up with biotech layoffs in 2026! Each week, the Labiotech team tracks and analyzes layoffs across the biotech industry, offering a clear, data-driven view of trends affecting companies, ...